Per capital sales of drug firms top 155 million won on average

Published: 2011-08-24 06:58:00

Updated: 2011-08-24 06:58:00

Per capita revenues of 30 pharmaceutical firms posted an average 155 million won in the first half of this year, according to Yakup.com.

The website’s latest data on the revenues of these pharmaceutical companies listed on the KOSPI and KOSDAQ markets showed the average employee has a selling ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK